1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997. 337:898–909.
2. Georgiades CS, Neyman EG, Barish MA, Fishman EK. Amyloidosis: review and CT manifestations. Radiographics. 2004. 24:405–416.
3. Urban BA, Fishman EK, Goldman SM, Scott WW Jr, Jones B, Humphrey RL, et al. CT evaluation of amyloidosis: spectrum of disease. Radiographics. 1993. 13:1295–1308.
4. Ozdemir D, Dagdelen S, Erbas T. Endocrine involvement in systemic amyloidosis. Endocr Pract. 2010. 16:1056–1063.
5. Garcia RL. Verrucose areolar hyperpigmentation of pregnancy. Arch Dermatol. 1973. 107:774.
6. Kennan NM, Evans C. Case report: hepatic and splenic calcification due to amyloid. Clin Radiol. 1991. 44:60–61.
7. Sainani N, Catalano O, Sahani D. Haaga JR, Dogra VS, Forsting M, Gilkeson RC, Ha HK, Sundaram M, editors. Pancreas. CT and MRI of the whole body. 2009. . Philadelphia: Mosby Elsevier;1599–1675.
8. Rafal RB, Jennis R, Kosovsky PA, Markisz JA. MRI of primary amyloidosis. Gastrointest Radiol. 1990. 15:199–201.
9. De Backer AI, Mortele KJ, Bomans P, De Keulenaer BL, Vanschoubroeck IJ, Kockx MM. Tuberculosis of the pancreas: MRI features. AJR Am J Roentgenol. 2005. 184:50–54.
10. Hoppener JW, Nieuwenhuis MG, Vroom TM, Ahren B, Lips CJ. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? Mol Cell Endocrinol. 2002. 197:205–212.